{"id":59884,"date":"2026-01-29T11:47:09","date_gmt":"2026-01-29T06:17:09","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=59884"},"modified":"2026-01-29T11:47:14","modified_gmt":"2026-01-29T06:17:14","slug":"accretion-nutraveda-ipo-gmp-subscription-day-2","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/accretion-nutraveda-ipo-gmp-subscription-day-2\/","title":{"rendered":"Accretion Nutraveda IPO GMP &#038; Subscription Status: Day 2 IPO Live Updates"},"content":{"rendered":"<p>The <strong>Accretion Nutraveda IPO GMP <\/strong>is \u20b90 as of 29th January 2026. It is a book-building issue IPO of \u20b924.77 crores. This is an entirely fresh issue of 0.19 crore shares. The issue will be listed on BSE and SME on its tentative listing date, 4th February 2026. The face value of Accretion Nutraveda IPO shares is \u20b910 per share, and the IPO price band is \u20b9122 to \u20b9129 per share. Retail investors can bid for a minimum of 2 lots of 2,000 shares worth \u20b92,58,000. Scroll down to check the Accretion Nutraveda IPO GMP and subscription details.<\/p><div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/accretion-nutraveda-ipo-gmp-subscription-day-2\/#Accretion_Nutraveda_IPO_GMP_Grey_Market_Premium\" title=\"Accretion Nutraveda IPO GMP Grey Market Premium\">Accretion Nutraveda IPO GMP Grey Market Premium<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/accretion-nutraveda-ipo-gmp-subscription-day-2\/#Accretion_Nutraveda_IPO_Subscription_Status\" title=\"Accretion Nutraveda IPO Subscription Status\">Accretion Nutraveda IPO Subscription Status<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/accretion-nutraveda-ipo-gmp-subscription-day-2\/#Accretion_Nutraveda_IPO_Details\" title=\"Accretion Nutraveda IPO Details\">Accretion Nutraveda IPO Details<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/accretion-nutraveda-ipo-gmp-subscription-day-2\/#Explanation\" title=\"Explanation\">Explanation<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/accretion-nutraveda-ipo-gmp-subscription-day-2\/#About_Accretion_Nutraveda_Ltd\" title=\"About Accretion Nutraveda Ltd.\">About Accretion Nutraveda Ltd.<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/accretion-nutraveda-ipo-gmp-subscription-day-2\/#Business_verticals\" title=\"Business verticals:\">Business verticals:<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/accretion-nutraveda-ipo-gmp-subscription-day-2\/#Accretion_Nutraveda_Limited_Financials\" title=\"Accretion Nutraveda Limited Financials\">Accretion Nutraveda Limited Financials<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/accretion-nutraveda-ipo-gmp-subscription-day-2\/#Explanation-2\" title=\"Explanation\">Explanation<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/accretion-nutraveda-ipo-gmp-subscription-day-2\/#Accretion_Nutraveda_IPO_Objectives\" title=\"Accretion Nutraveda IPO Objectives\">Accretion Nutraveda IPO Objectives<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/accretion-nutraveda-ipo-gmp-subscription-day-2\/#Accretion_Nutraveda_IPO_Registrar\" title=\"Accretion Nutraveda IPO Registrar\">Accretion Nutraveda IPO Registrar<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/accretion-nutraveda-ipo-gmp-subscription-day-2\/#Accretion_Nutraveda_IPO_Review\" title=\"Accretion Nutraveda IPO Review\">Accretion Nutraveda IPO Review<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/accretion-nutraveda-ipo-gmp-subscription-day-2\/#FAQs_on_Accretion_Nutraveda_IPO\" title=\"FAQs on Accretion Nutraveda IPO\">FAQs on Accretion Nutraveda IPO<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/accretion-nutraveda-ipo-gmp-subscription-day-2\/#What_is_the_Accretion_Nutraveda_IPO_GMP\" title=\"What is the Accretion Nutraveda IPO GMP?\">What is the Accretion Nutraveda IPO GMP?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/accretion-nutraveda-ipo-gmp-subscription-day-2\/#What_is_the_issue_price_of_the_Accretion_Nutraveda_IPO\" title=\"What is the issue price of the Accretion Nutraveda IPO?\">What is the issue price of the Accretion Nutraveda IPO?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/accretion-nutraveda-ipo-gmp-subscription-day-2\/#Who_is_the_registrar_of_the_Accretion_Nutraveda_IPO\" title=\"Who is the registrar of the Accretion Nutraveda IPO?\">Who is the registrar of the Accretion Nutraveda IPO?<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/accretion-nutraveda-ipo-gmp-subscription-day-2\/#Recent_Articles\" title=\"Recent Articles\">Recent Articles<\/a><\/li><\/ul><\/nav><\/div>\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Accretion_Nutraveda_IPO_GMP_Grey_Market_Premium\"><\/span><strong>Accretion Nutraveda IPO GMP Grey Market Premium<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p>As mentioned earlier, the <strong>Accretion Nutraveda IPO GMP <\/strong>currently stands at \u20b90.00 per share. Thus, the estimated listing price would be at \u20b9129.00. This indicates that the estimated listing gain in this IPO could be 0.00%. Explore the table for <strong>Accretion Nutraveda<\/strong> <strong>IPO GMP<\/strong> updates.<\/p><figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><tbody><tr><td><strong>GMP DATE<\/strong><\/td><td><strong>IPO Price<\/strong><\/td><td><strong>GMP Price<\/strong><\/td><td><strong>Estimated Listing Price<\/strong><\/td><td><strong>Estimated Gain<\/strong><\/td><\/tr><tr><td><strong>29-01-2026<\/strong><\/td><td>\u20b9129.00<\/td><td>\u20b90.00<\/td><td>\u20b9129.00<\/td><td>0.00%<\/td><\/tr><tr><td><strong>28-01-2026<\/strong><\/td><td>\u20b9129.00<\/td><td>\u20b90.00<\/td><td>\u20b9129.00<\/td><td>0.00%<\/td><\/tr><tr><td><strong>27-01-2026<\/strong><\/td><td>\u20b9129.00<\/td><td>\u20b90.00<\/td><td>\u20b9129.00<\/td><td>0.00%<\/td><\/tr><tr><td><strong>26-01-2026<\/strong><\/td><td>\u20b9129.00<\/td><td>\u20b90.00<\/td><td>\u20b9129.00<\/td><td>0.00%<\/td><\/tr><tr><td><strong>25-01-2026<\/strong><\/td><td>\u20b9129.00<\/td><td>\u20b90.00<\/td><td>\u20b9129.00<\/td><td>0.00%<\/td><\/tr><tr><td><strong>24-01-2026<\/strong><\/td><td>\u20b9129.00<\/td><td>\u20b90.00<\/td><td>\u20b9129.00<\/td><td>0.00%<\/td><\/tr><tr><td><strong>23-01-2026<\/strong><\/td><td>\u20b9129.00<\/td><td>\u20b90.00<\/td><td>\u20b9129.00<\/td><td>0.00%<\/td><\/tr><tr><td><strong>22-01-2026<\/strong><\/td><td>\u20b9129.00<\/td><td>\u20b90.00<\/td><td>\u20b9129.00<\/td><td>0.00%<\/td><\/tr><tr><td><strong>21-01-2026<\/strong><\/td><td>\u20b9129.00<\/td><td>\u20b90.00<\/td><td>\u20b9129.00<\/td><td>0.00%<\/td><\/tr><\/tbody><\/table><\/figure><p><em>Note: GMP details are subject to change based on market conditions and fluctuations. Check the live Accretion Nutraveda IPO GMP status at Univest.<\/em><\/p><p><a href=\"https:\/\/univest.in\/user\/log-in\"><strong><em>Click and Sign Up to Get Live Updates on Accretion Nutraveda IPO <\/em><\/strong><strong>GMP Status<\/strong><\/a><\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Accretion_Nutraveda_IPO_Subscription_Status\"><\/span><strong>Accretion Nutraveda IPO Subscription Status<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p>As of now, the Accretion Nutraveda IPO has been subscribed to 0.16 times. Of these, 0.24 times are subscribed by retail investors, 0.17 times by non-institutional investors, and 0.00 times by QII (Qualified Institutional Investors).&nbsp;&nbsp;<\/p><p>The healthy subscription status indicates that investors are expecting higher returns at the time of Accretion Nutraveda&#8217;s IPO listing on 4th February 2026. Accretion Nutraveda also has a positive outlook behind the fresh issue of 0.19 crore shares, which will raise around Rs 24.77 crores.<\/p><p><strong><em>Note:<\/em><\/strong><em> GMP details are subject to change based on market conditions and fluctuations. Check the live Accretion Nutraveda IPO Subscription status at Univest.<\/em><\/p><p><a href=\"https:\/\/univest.in\/user\/log-in\"><strong><em>Click and Sign Up to Get Live Updates on Accretion Nutraveda IPO Subscription<\/em><\/strong><strong> Status<\/strong><\/a><\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Accretion_Nutraveda_IPO_Details\"><\/span><strong>Accretion Nutraveda IPO Details<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><tbody><tr><td><strong>IPO Allotment Date<\/strong><\/td><td>2nd February 2026<\/td><\/tr><tr><td><strong>IPO Open Date<\/strong><\/td><td>28th January 2026<\/td><\/tr><tr><td><strong>IPO Close Date<\/strong><\/td><td>30th January 2026<\/td><\/tr><tr><td><strong>Refund Initiation&nbsp;<\/strong><\/td><td>3rd February 2026<\/td><\/tr><tr><td><strong>Issue Size<\/strong><\/td><td>19,20,000 shares(agg. up to \u20b925 Cr)<\/td><\/tr><tr><td><strong>Face Value<\/strong><\/td><td>\u20b910 per share<\/td><\/tr><tr><td><strong>Lot Size<\/strong><\/td><td>2,000 Shares<\/td><\/tr><tr><td><strong>Issue Price&nbsp;<\/strong><\/td><td>\u20b9122 to \u20b9129 per share<\/td><\/tr><tr><td><strong>Issue Type<\/strong><\/td><td>Bookbuilding IPO<\/td><\/tr><tr><td><strong>Listing At<\/strong><\/td><td>BSE SME<\/td><\/tr><tr><td><strong>Listing Date<\/strong><\/td><td>4th February 2026<\/td><\/tr><\/tbody><\/table><\/figure><p><strong><em>Also Read: <\/em><\/strong><a href=\"https:\/\/univest.in\/blogs\/aritas-vinyl-ipo-gmp-review\"><strong><em>Accretion Nutraveda IPO GMP &amp; Review: Apply or Avoid?<\/em><\/strong><\/a><\/p><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Explanation\"><\/span><strong>Explanation<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p><strong>Accretion Nutraveda IPO<\/strong>: Accretion Nutraveda IPO Limited has declared an issue price band of \u20b9122 to \u20b9129 per share. With this IPO, the company allows retail investors to bid for at least 2 lots of 2,000 shares, each worth \u20b92,58,000. The face value of Accretion Nutraveda IPO Limited shares is \u20b910 per share. The shares of Accretion Nutraveda IPO Limited will be listed on BSE and SME on its tentative listing day, 4th February 2026. Scroll down to check GMP updates and <strong>Accretion Nutraveda IPO <\/strong>reviews.&nbsp;<\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"About_Accretion_Nutraveda_Ltd\"><\/span><strong>About Accretion Nutraveda Ltd.<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p>Accretion Nutraveda Limited was established in 2021, Accretion Nutraveda is engaged in the manufacturing of Ayurvedic and Nutraceutical products in various dosage forms, including tablets, capsules, oral liquids, powders, oils, and external preparations like balms, creams, and gels The company operates as a Contract Development and Manufacturing Organization (CDMO), serving both domestic and international markets such as Sri Lanka, Singapore, and the USA. Its products combine classical Ayurvedic principles with modern nutraceutical science to address areas like liver care, women\u2019s health, bone and joint health, cognitive support, and respiratory wellness.<\/p><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Business_verticals\"><\/span><strong>Business verticals:<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><ol class=\"wp-block-list\"><li><strong>Domestic Sales &amp; Merchant Exports (Loan License Basis)<\/strong>\u2013 contributing 96.62% of total revenue in FY 2024-25.<\/li>\n\n<li><strong>Direct Exports<\/strong>\u2013 Contributing 38%, showing consistent growth.<\/li><\/ol><p>It has a manufacturing facility in Gujarat that covers about 10,763 sq. ft., equipped with modern infrastructure, including 13 air handling units, separate processing areas, and quality control systems. The facility is GMP, WHO-GMP, FSSC 22000, ISO 9001:2015, ISO 45001:2018, and Halal certified, with an FSSAI license.<\/p><p><strong>Also Read-<\/strong> <a href=\"https:\/\/univest.in\/blogs\/accretion-nutraveda-ipo-gmp-review\">Accretion Nutraveda IPO GMP &amp; Review: Apply or Avoid?<\/a><\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Accretion_Nutraveda_Limited_Financials\"><\/span><strong>Accretion Nutraveda Limited Financials<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p>The company&#8217;s financial analysis is essential before applying for the<strong> Accretion Nutraveda IPO. <\/strong>Look at the table to learn about Accretion Nutraveda Limited&#8217;s financials.&nbsp;<\/p><figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><tbody><tr><td><strong>Year Ended<\/strong><\/td><td><strong>30th Sep 2025 (in cr.)<\/strong><\/td><td><strong>31st March 2025 (in cr.)<\/strong><\/td><td><strong>31st March 2024 (in cr.)<\/strong><\/td><td><strong>31st March 2023 (in cr.)<\/strong><\/td><\/tr><tr><td><strong>Assets<\/strong><\/td><td>16.35<\/td><td>10.86<\/td><td>4.64<\/td><td>4.06<\/td><\/tr><tr><td><strong>Revenue<\/strong><\/td><td>14.07<\/td><td>16.06<\/td><td>5.20<\/td><td>3.07<\/td><\/tr><tr><td><strong>Profit After Tax<\/strong><\/td><td>2.33<\/td><td>2.61<\/td><td>0.82<\/td><td>0.28<\/td><\/tr><tr><td><strong>EBITDA<\/strong><\/td><td>3.29<\/td><td>3.65<\/td><td>1.21<\/td><td>0.59<\/td><\/tr><tr><td><strong>Net Worth<\/strong><\/td><td>8.26<\/td><td>5.35<\/td><td>1.08<\/td><td>0.26<\/td><\/tr><tr><td><strong>Reserves and Surplus<\/strong><\/td><td>2.95<\/td><td>4.86<\/td><td>0.72<\/td><td>-0.10<\/td><\/tr><tr><td><strong>Total Borrowings<\/strong><\/td><td>4.43<\/td><td>3.86<\/td><td>2.17<\/td><td>1.97<\/td><\/tr><\/tbody><\/table><\/figure><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Explanation-2\"><\/span><strong>Explanation<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>Accretion Nutraveda Limited&#8217;s revenue increased by 208.84% from \u20b95.20 crores in March 2024 to \u20b916.06 crores in March 2025. Moreover, the company&#8217;s PAT increased by 218.29% from \u20b90.82 crores in March 2024 to \u20b92.61 crores in March 2025.<\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Accretion_Nutraveda_IPO_Objectives\"><\/span><strong>Accretion Nutraveda IPO Objectives<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p>The primary aim of the <strong>Accretion Nutraveda IPO<\/strong> is to raise \u20b924.77 crores. On the other hand, Accretion Nutraveda has decided to utilise these funds in different ways.<\/p><ul class=\"wp-block-list\"><li>To purchase machinery for Automation in the existing Manufacturing unit<\/li>\n\n<li>To Purchase Machinery for the New Manufacturing Setup<\/li>\n\n<li>To General Corporate Expenses.<\/li>\n\n<li>To fund the working capital requirements of our company<\/li><\/ul><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Accretion_Nutraveda_IPO_Registrar\"><\/span><strong>Accretion Nutraveda IPO Registrar<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p>Kfin Technologies Limited is the registrar for the Accretion Nutraveda IPO, awaiting the allotment process and initiating refunds. For any queries regarding the Accretion Nutraveda allotment and refund, you can contact Kfin Technologies Limited at <a href=\"mailto:apl.ipo@kfintech.com\">apl.ipo@kfintech.com<\/a> or at 04067162222, 04079611000.<\/p><p><strong><em>Download the <\/em><\/strong><a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\"><strong><em>Univest iOS App<\/em><\/strong><\/a><strong><em> or <\/em><\/strong><a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&amp;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\"><strong><em>Univest Android App<\/em><\/strong><\/a><strong><em> to get daily stock recommendations and insightful research pieces!<\/em><\/strong>&nbsp;<\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Accretion_Nutraveda_IPO_Review\"><\/span><strong>Accretion Nutraveda IPO Review<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><figure class=\"wp-block-image size-large\"><img fetchpriority=\"high\" decoding=\"async\" width=\"1024\" height=\"536\" src=\"https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2026\/01\/29114515\/Accretion-Nutraveda-IPO-Apply-or-Avoid-1-1024x536.jpg\" alt=\"Accretion Nutraveda IPO Review\n\" class=\"wp-image-59886\" srcset=\"https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2026\/01\/29114515\/Accretion-Nutraveda-IPO-Apply-or-Avoid-1-1024x536.jpg 1024w, https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2026\/01\/29114515\/Accretion-Nutraveda-IPO-Apply-or-Avoid-1-300x157.jpg 300w, https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2026\/01\/29114515\/Accretion-Nutraveda-IPO-Apply-or-Avoid-1-768x402.jpg 768w, https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2026\/01\/29114515\/Accretion-Nutraveda-IPO-Apply-or-Avoid-1-900x471.jpg 900w, https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2026\/01\/29114515\/Accretion-Nutraveda-IPO-Apply-or-Avoid-1-600x314.jpg 600w, https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2026\/01\/29114515\/Accretion-Nutraveda-IPO-Apply-or-Avoid-1-150x79.jpg 150w, https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2026\/01\/29114515\/Accretion-Nutraveda-IPO-Apply-or-Avoid-1.jpg 1200w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/><\/figure><p>The <strong>Accretion Nutraveda IPO <\/strong>has gained neutral ratings from industry experts, brokers, and institutional investors. Accretion Nutraveda Limited&#8217;s revenue increased by 208.84% from \u20b95.20 crores in March 2024 to \u20b916.06 crores in March 2025. Moreover, the company&#8217;s PAT increased by 218.29% from \u20b90.82 crores in March 2024 to \u20b92.61 crores in March 2025.<\/p><p>Most analysts recommend applying for this IPO to diversify your investment portfolio. However, we\u2019re waiting for additional ratings to get a clearer picture and will keep posting them to deliver real-time insights. Until then, you can explore the company&#8217;s technical analysis to know whether you should apply for the <strong>Accretion Nutraveda IPO <\/strong>or not.<\/p><figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><tbody><tr><td><strong>Key Indicators<\/strong><\/td><td><strong>Value<\/strong><\/td><\/tr><tr><td><a href=\"https:\/\/univest.in\/blogs\/price-to-earnings-ratio-p-e-ratio\"><strong>PE Ratio (Price-to-Earnings)<\/strong><\/a><strong>&nbsp;<\/strong><\/td><td>26.27<\/td><\/tr><tr><td><a href=\"https:\/\/univest.in\/blogs\/earnings-per-share-eps-formula\"><strong>EPS (Earnings Per Share)<\/strong><\/a><\/td><td>4.91<\/td><\/tr><tr><td><strong>RoNW<\/strong><\/td><td>56.50%<\/td><\/tr><tr><td><a href=\"https:\/\/univest.in\/blogs\/return-on-capital-employed\"><strong>ROCE<\/strong><\/a><\/td><td>49.09%<\/td><\/tr><tr><td><strong>ROE<\/strong><\/td><td>68.54%<\/td><\/tr><tr><td><strong>EBITDA Margin<\/strong><\/td><td>23.36%<\/td><\/tr><tr><td><strong>Price to Book Value<\/strong><\/td><td>7.71<\/td><\/tr><tr><td><strong>Market Capitalisation<\/strong><\/td><td>\u20b993.40 Cr<\/td><\/tr><\/tbody><\/table><\/figure><p>The P\/E ratio of Accretion Nutraveda Limited shares is 26.27, and its Earnings Per Share (EPS) stands at 4.91. Thus, the <strong>Accretion Nutraveda IPO<\/strong> can deliver gains on its tentative listing date, 4th February 2026.&nbsp;<\/p><p><strong><em>Note<\/em><\/strong><em>: The data, as mentioned above, is taken from authentic sources and highlights pre-issue information. The PE ratio and EPS of Accretion Nutraveda Limited are subject to change after the IPO. Explore the table below to get post-issue updates on these two metrics.&nbsp;<\/em><\/p><figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><tbody><tr><td><strong>Indicators<\/strong><\/td><td><strong>Pre-IPO<\/strong><\/td><td><strong>Post-IPO<\/strong><\/td><\/tr><tr><td><strong>PE Ratio<\/strong><\/td><td>26.27<\/td><td>20.02<\/td><\/tr><tr><td><strong>EPS&nbsp;<\/strong><\/td><td>4.91<\/td><td>6.44<\/td><\/tr><\/tbody><\/table><\/figure><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"FAQs_on_Accretion_Nutraveda_IPO\"><\/span><strong>FAQs on Accretion Nutraveda IPO<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"What_is_the_Accretion_Nutraveda_IPO_GMP\"><\/span><strong>What is the Accretion Nutraveda IPO GMP?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>Currently, on 29th January 2026, the <strong>Accretion Nutraveda IPO GMP<\/strong> (Grey Market Premium) stands at \u20b90. This indicates that the estimated listing price could be \u20b9129.00 per share.<\/p><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"What_is_the_issue_price_of_the_Accretion_Nutraveda_IPO\"><\/span><strong>What is the issue price of the Accretion Nutraveda IPO?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>The <strong>Accretion Nutraveda IPO<\/strong> issue price band is set at \u20b9122.00 to \u20b9129.00 per share. Retail investors can apply for a minimum of 2 lots, each consisting of 2,000 shares, worth \u20b92,58,000. Moreover, HNIs are required to bid for a minimum of 3 lots (3,000 shares) worth \u20b93,87,000.<\/p><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Who_is_the_registrar_of_the_Accretion_Nutraveda_IPO\"><\/span><strong>Who is the registrar of the Accretion Nutraveda IPO?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>Kfin Technologies Limited is the registrar for the Accretion Nutraveda IPO, awaiting the allotment process and initiating refunds. For any queries regarding the Accretion Nutraveda allotment and refund, you can contact Kfin Technologies Limited at <a href=\"mailto:apl.ipo@kfintech.com\">apl.ipo@kfintech.com<\/a> or at 04067162222, 04079611000.<\/p><p><strong><em>Disclaimer<\/em><\/strong><em>: The above information is compiled from authentic sources and is just for informational purposes. To have detailed information about the Accretion Nutraveda IPO, download the Accretion Nutraveda IPO RHP and Accretion Nutraveda IPO DRHP. Conduct your research before investing in IPOs to avoid significant losses. You can also consult your financial advisor.<\/em><\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Recent_Articles\"><\/span><strong>Recent Articles<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p><a href=\"https:\/\/univest.in\/blogs\/kasturi-metal-composite-ipo-gmp-subscription-day-2\">Kasturi Metal Composite IPO GMP &amp; Subscription Status: Day 2 IPO Live Updates<\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/accretion-nutraveda-ipo-gmp-subscription-day-1\">Accretion Nutraveda IPO GMP &amp; Subscription Status: Day 1 IPO Live Updates<\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/msafe-equipments-ipo-gmp-subscription-day-1\">Msafe Equipments IPO GMP &amp; Subscription Status: Day 1 IPO Live Updates<\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/kanishk-aluminium-india-ipo-gmp-subscription-day-1\">Kanishk Aluminium India IPO GMP &amp; Subscription Status: Day 1 IPO Live Updates<\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/digilogic-systems-ipo-listing\">Digilogic Systems IPO Listing at 20.00% discount at 83.20 Per Share<\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/shadowfax-technologies-ipo-listing\">Shadowfax Technologies IPO Listing at 9.00% discount at 112.60 Per Share<\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>The Accretion Nutraveda IPO GMP is \u20b90 as of 29th January 2026. It is a book-building issue IPO of \u20b924.77 crores. This is an entirely fresh issue of 0.19 crore shares. The issue will be listed on BSE and SME on its tentative listing date, 4th February 2026. The face value of Accretion Nutraveda IPO<\/p>\n","protected":false},"author":23,"featured_media":59885,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1281],"tags":[1015,1352,3806],"class_list":["post-59884","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-ipo","tag-ipo","tag-ipo-gmp","tag-ipo-subscription"],"metadata":{"_edit_lock":["1769667437:23"],"_last_editor_used_jetpack":["block-editor"],"rank_math_internal_links_processed":["1"],"amazonS3_cache":["a:4:{s:92:\"\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/01\/Accretion-Nutraveda-IPO-Apply-or-Avoid-1.jpg\";a:2:{s:2:\"id\";i:59886;s:11:\"source_type\";s:13:\"media-library\";}s:101:\"\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/01\/Accretion-Nutraveda-IPO-Apply-or-Avoid-1-1024x536.jpg\";a:2:{s:2:\"id\";i:59886;s:11:\"source_type\";s:13:\"media-library\";}s:124:\"\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2026\/01\/29114515\/Accretion-Nutraveda-IPO-Apply-or-Avoid-1.jpg\";a:2:{s:2:\"id\";i:59886;s:11:\"source_type\";s:13:\"media-library\";}s:133:\"\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2026\/01\/29114515\/Accretion-Nutraveda-IPO-Apply-or-Avoid-1-1024x536.jpg\";a:2:{s:2:\"id\";i:59886;s:11:\"source_type\";s:13:\"media-library\";}}"],"rank_math_primary_category":["1281"],"rank_math_seo_score":["77"],"rank_math_title":["Accretion Nutraveda IPO GMP Subscription Status Day 2"],"rank_math_description":["Accretion Nutraveda IPO GMP, Subscription status. Explore for further information about the Accretion Nutraveda IPO. Read more!\n"],"rank_math_focus_keyword":["Accretion Nutraveda IPO GMP,Accretion Nutraveda IPO,Accretion Nutraveda IPO Subscription"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"],"_thumbnail_id":["59885"],"_edit_last":["23"],"_ez-toc-disabled":[""],"_ez-toc-insert":[""],"_ez-toc-header-label":[""],"_ez-toc-alignment":["none"],"_ez-toc-heading-levels":["a:0:{}"],"_ez-toc-alttext":[""],"_ez-toc-visibility_hide_by_default":[""],"_ez-toc-hide_counter":[""],"_ez-toc-exclude":[""],"_ez-toc-position-specific":["before"],"stm_select_gm_zoom":[""],"stm_agenda":[""],"stm_host":[""],"stm_select_approved_denied":[""],"stm_multiselect_approved":[""],"stm_multiselect_denied":[""],"stm_date":[""],"stm_time":[""],"stm_timezone":[""],"stm_duration":[""],"stm_password":[""],"stm_waiting_room":[""],"stm_join_before_host":[""],"stm_host_join_start":[""],"stm_start_after_participants":[""],"stm_mute_participants":[""],"stm_enforce_login":[""],"stm_alternative_hosts":[""],"top_bar_custom_style":[""],"top_bar_bg":[""],"wc_top_bar_cart_custom_style":[""],"wc_top_bar_cart_color":[""],"wc_top_bar_cart_icon_color_hover":[""],"wc_top_bar_cart_counter_color":[""],"wc_top_bar_cart_counter_color_hover":[""],"wc_top_bar_cart_counter_bg":[""],"wc_top_bar_cart_counter_bg_hover":[""],"top_bar_wpml_switcher_custom_style":[""],"wpml_switcher_color":[""],"top_bar_wpml_switcher_bg":[""],"top_bar_wpml_switcher_bg_hover":[""],"top_bar_wpml_switcher_color_hover":[""],"top_bar_socials_custom_style":[""],"top_bar_socials_color":[""],"top_bar_socials_color_hover":[""],"top_bar_search_custom_style":[""],"top_bar_search_color":[""],"top_bar_search_icon_color_hover":[""],"top_bar_contact_info_style":[""],"top_bar_contact_info_color":[""],"top_bar_contact_info_link_color":[""],"top_bar_contact_info_link_color_hover":[""],"top_bar_contact_info_select_bg":[""],"top_bar_contact_info_select_color":[""],"top_bar_contact_info_select_drop_bg":[""],"top_bar_contact_info_select_items_bg":[""],"top_bar_contact_info_select_items_color":[""],"top_bar_contact_info_select_items_hover":[""],"header_inverse":["default"],"enable_header_transparent":["off"],"header_nav_custom_style":[""],"header_bg":[""],"header_shadow":[""],"wc_cart_custom_style":[""],"wc_cart_icon_color":[""],"wc_cart_icon_color_hover":[""],"wc_cart_counter_color":[""],"wc_cart_counter_color_hover":[""],"wc_cart_counter_bg":[""],"wc_cart_counter_bg_hover":[""],"header_wpml_switcher_custom_style":[""],"header_wpml_switcher_color":[""],"header_wpml_switcher_color_hover":[""],"header_wpml_switcher_bg":[""],"header_wpml_switcher_bg_hover":[""],"header_socials_custom_style":[""],"header_socials_color":[""],"header_socials_color_hover":[""],"header_search_custom_style":[""],"header_search_icon_color":[""],"header_search_icon_color_hover":[""],"header_contact_info_style":[""],"header_contact_info_color":[""],"header_contact_info_link_color":[""],"header_contact_info_link_color_hover":[""],"header_button_custom_style":[""],"header_button_color":[""],"header_button_color_hover":[""],"header_button_bg":[""],"header_button_bg_hover":[""],"header_nav_menu_customize":[""],"header_nav_menu_link_color":[""],"header_nav_menu_link_color_hover":[""],"header_nav_menu_link_color_active":[""],"header_nav_menu_link_arrow_color":[""],"header_nav_menu_link_arrow_color_hover":[""],"header_nav_menu_level_1_bg":[""],"header_nav_menu_level_1_link_color":[""],"header_nav_menu_level_1_link_color_hover":[""],"header_nav_menu_level_1_link_bg_hover":[""],"header_nav_menu_level_1_link_arrow_color":[""],"header_nav_menu_level_1_link_arrow_color_hover":[""],"header_nav_menu_level_2_bg":[""],"header_nav_menu_level_2_link_color":[""],"header_nav_menu_level_2_link_color_hover":[""],"header_nav_menu_level_2_link_bg_hover":[""],"header_mega_menu_bg":[""],"header_mega_menu_title_color":[""],"header_mega_menu_title_color_hover":[""],"header_mega_menu_description_color":[""],"header_mega_menu_description_link_color":[""],"header_mega_menu_description_link_color_hover":[""],"header_mega_menu_color":[""],"header_mega_menu_color_hover":[""],"header_mega_menu_border_color":[""],"header_mega_menu_icons_color":[""],"header_nav_menu_customize_end":[""],"hfe_enabled_notice":[""],"disable_title_box":["default"],"hfe_disabled":[""],"enable_transparent":["default"],"title_box_title_bg_color":[""],"title_box_bg_custom_image":["default"],"title_box_bg_image":[""],"title_box_bg_position":["default"],"metabox_title_box_bg_position_x":[""],"metabox_title_box_bg_position_y":[""],"metabox_title_box_bg_attachment":["default"],"title_box_bg_size":["default"],"metabox_title_box_bg_size_slider":[""],"title_box_bg_repeat":["default"],"disable_title":["default"],"title_box_title_color":[""],"title_box_title_line_color":[""],"disable_breadcrumbs":["default"],"metabox_title_box_breadcrumbs_color":[""],"metabox_title_box_links_color":[""],"metabox_title_box_links_color_hover":[""],"content_bg_transparent":[""],"show_popup_single":[""],"popups_single":[""],"popups_single_event":[""],"popup_single_event_open_delay":[""],"popup_single_event_showing_in":[""],"popup_single_event_date_from":[""],"popup_single_event_date_to":[""],"popup_single_event_time_from":[""],"popup_single_event_time_to":[""],"popup_single_animation":[""],"popup_single_responsive":[""],"separator_footer_copyright_border_t":[""],"name":[""],"email":[""],"phone":[""],"company":[""],"memberId":[""],"testimonial_position":[""],"testimonial_company":[""],"testimonial_bg_img":[""],"testimonial_video_url":[""],"popups_width":[""],"popups_height":[""],"popups_image_bg":[""],"popups_color_bg":[""],"popups_border_radius":[""],"popups_template":[""],"rank_math_analytic_object_id":["5937"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2026\/01\/29114242\/Accretion-Nutraveda-GMP-Subscription-Status-Day-2.jpg","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/59884","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/23"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=59884"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/59884\/revisions"}],"predecessor-version":[{"id":59887,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/59884\/revisions\/59887"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/59885"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=59884"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=59884"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=59884"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}